Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- G. Richard Smith, M.D., Is New Chair of Psychiatry
Smith appointed chair of Department of Psychiatry and Behavioral Sciences.
- G. Richard Smith, M.D., Is New Chair of Psychiatry
Smith appointed chair of Department of Psychiatry and Behavioral Sciences.
- G. Richard Smith, M.D., Is New Chair of Psychiatry
Smith appointed chair of Department of Psychiatry and Behavioral Sciences.
- G. Richard Smith, M.D., Is New Chair of Psychiatry
Smith appointed chair of Department of Psychiatry and Behavioral Sciences.
- UAMS Welcomes Seven New Faculty
Seven new faculty members recently joined the University of Arkansas for Medical Sciences (UAMS).
- UAMS Welcomes Seven New Faculty
Seven new faculty members recently joined the University of Arkansas for Medical Sciences (UAMS).
- University Hospital Is Ready in an Emergency
University Hospital at UAMS is ready for large disasters or emergencies when they occur.
- University Hospital Is Ready in an Emergency
University Hospital at UAMS is ready for large disasters or emergencies when they occur.
- University Hospital Is Ready in an Emergency
University Hospital at UAMS is ready for large disasters or emergencies when they occur.
- Clinic Provides Complete Care for Epilepsy Patients
The Epilepsy Clinic at UAMS Medical Center is a comprehensive program for diagnosing and treating epilepsy.
- Clinic Provides Complete Care for Epilepsy Patients
The Epilepsy Clinic at UAMS Medical Center is a comprehensive program for diagnosing and treating epilepsy.
- Where Medicine Lives and Babies are Born
Where Medicine Lives and Babies are Born - Katrina R. Davis, M.D.
- One-of-a-Kind Program Cares for High-Risk Pregnancies
The Arkansas High-Risk Pregnancy Program at UAMS Medical Center is the only one of its kind in the state.
- One-of-a-Kind Program Cares for High-Risk Pregnancies
The Arkansas High-Risk Pregnancy Program at UAMS Medical Center is the only one of its kind in the state.
- One-of-a-Kind Program Cares for High-Risk Pregnancies
The Arkansas High-Risk Pregnancy Program at UAMS Medical Center is the only one of its kind in the state.
- Redbook Recognizes UAMS Breast Cancer Specialists
Two breast cancer specialists at Arkansas Cancer Research Center at UAMS recently appeared in a list of “Top Breast Doctors in America” in the October issue of the popular women’s magazine, Redbook.
- Redbook Recognizes UAMS Breast Cancer Specialists
Two breast cancer specialists at Arkansas Cancer Research Center at UAMS recently appeared in a list of “Top Breast Doctors in America” in the October issue of the popular women’s magazine, Redbook.
- Redbook Recognizes UAMS Breast Cancer Specialists
Two breast cancer specialists at Arkansas Cancer Research Center at UAMS recently appeared in a list of “Top Breast Doctors in America” in the October issue of the popular women’s magazine, Redbook.
- Alzheimer’s Disease Center Opens at UAMS
UAMS has established an Alzheimer’s Disease Center to focus research and education on this debilitating form of dementia.
- Alzheimer’s Disease Center Opens at UAMS
UAMS has established an Alzheimer’s Disease Center to focus research and education on this debilitating form of dementia.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- 50 Years of People, Progress and Promise
In its 50-year history, the Department of Psychiatry within the UAMS College of Medicine has had three chairmen. William Reese, M.D., held the title from 1951-1985; Frederick Guggenheim, M.D., chaired from 1985-2000; and in 2001, UAMS College of Medicine alum G. Richard Smith, M.D., was appointed to lead the department.
- Schmieding Center Plans Are Great News for Northwest Arkansas, UA
UAMS Chancellor I. Dodd Wilson, M.D., praised Springdale philanthropist Lawrence H. Schmieding for his vision and generosity in creating a center for geriatric care and health care education.
- Schmieding Center Plans Are Great News for Northwest Arkansas, UA
UAMS Chancellor I. Dodd Wilson, M.D., praised Springdale philanthropist Lawrence H. Schmieding for his vision and generosity in creating a center for geriatric care and health care education.
- Schmieding Center Plans Are Great News for Northwest Arkansas, UA
UAMS Chancellor I. Dodd Wilson, M.D., praised Springdale philanthropist Lawrence H. Schmieding for his vision and generosity in creating a center for geriatric care and health care education.
- Don’t Let Bladder Control Problems Control You.
Don’t Let Bladder Control Problems Control You.
- A Guide for Understanding TomoTherapy®
A Guide for Understanding TomoTherapy
- I AM...Powerful, Innovative TeamTreatmentTM of Cancer
I AM...Powerful, Innovative TeamTreatment of Cancer
- Childbirth Doesn't Have to Mean Incontinence and Pelvic Disorders
Childbirth Doesn't Have to Mean Incontinence and Pelvic Disorders
- Cancer Can Be Cured
Cancer Can Be Cured
- Leading a Comprehensive Cancer Team
Leading a Comprehensive Cancer Team
- Orthopaedic Excellence
Orthopaedic Excellence
- Is There a Way to Prevent Growing Senile?
Is There a Way to Prevent Going Senile?
- Where Medicine Lives and Babies are Born.
Where Medicine Lives and Babies are Born - Wendell
- Where Medicine Lives and Babies are Born.
Where Medicine Lives and Babies are Born - Dr. Kay
- Where Medicine Lives and Babies are Born.
Where Medicine Lives and Babies are Born - Lowery
- Melanoma Monday Stresses Awareness, Early Detection and Prevention of Skin Cancer
Just in time for swimsuit weather, Melanoma Monday and National Skin Examination Day (May 2) reminds Americans to enjoy the sunshine – with limitations.
- Liver Transplant Program: Fact Sheet # 2
Liver Program Fact Sheet # 2
- Liver Transplant Program Facts Sheet #1
UAMS Creates Liver Transplant Program Facts Sheet #1
- Liver Transplant Program Facts Sheet #3
UAMS Creates Liver Transplant Program Facts Sheet #3
- Announcing A Scientifically Proven Breakthrough for Solving Back Pain
Announcing A Scientifically Proven Breakthrough for Solving Back Pain
- Taking Home Baby
Three out of four women patients of the in vitro fertilization program of the University of Arkansas for Medical Sciences in the last year have produced what’s called a “take home baby” — a healthy baby.
- Enjoy Clearer Vision Without Glasses or Contact Lenses - LASIK Surgery
Enjoy Clearer Vision Without Glasses or Contact Lenses - LASIK Surgery
- THE HEROES AMONG US
The Arkansas Cancer Research Center is proud to support Lance Armstrong in his quest for an unprecedented
seventh Tour de France victory. Regardless of the outcome of this year's race, Lance has already won the respect and admiration of millions of cancer survivors around the world who see him as more than a championship athlete, they see him as one of them. The ACRC is looking for stories of heroes, people who have taken on cancer and beaten it. If you or someone you know has a story about their encounters with cancer and would like to share it with others, please send it to us (see flip side). Some of those stories will be published. Write today. Just because you've never worn a yellow jersey doesn't mean you aren't a hero.
- THE HEROES AMONG US
The Arkansas Cancer Research Center is proud to support Lance Armstrong in his quest for an unprecedented
seventh Tour de France victory. Regardless of the outcome of this year's race, Lance has already won the respect and admiration of millions of cancer survivors around the world who see him as more than a championship athlete, they see him as one of them. The ACRC is looking for stories of heroes, people who have taken on cancer and beaten it. If you or someone you know has a story about their encounters with cancer and would like to share it with others, please send it to us (see flip side). Some of those stories will be published. Write today. Just because you've never worn a yellow jersey doesn't mean you aren't a hero.
- Stop Chronic Pain in Its Tracks
Stop Chronic Pain in Its Tracks
- Why Are Digital Mammograms Better?
Why Are Digital Mammograms Better?
- Why Are Digital Mammograms Better?
Why Are Digital Mammograms Better?
- Awareness Can Keep Glaucoma From Stealing Sight, Says UAMS Specialist
Awareness Can Keep Glaucoma From Stealing Sight, Says UAMS Specialist
- Awareness Can Keep Glaucoma From Stealing Sight, Says UAMS Specialist
Awareness Can Keep Glaucoma From Stealing Sight, Says UAMS Specialist
- UAMS Executive Physical Program: Preventive Visit Plan Details
UAMS Executive Physical Program: Preventive Visit Plan Details
- UAMS Certified Interpreters
UAMS Certified Interpreters
- UAMS Certified Interpreters
UAMS Certified Interpreters
- UAMS Certified Interpreters
UAMS Certified Interpreters
- Thyroid Diseases
Thyroid Diseases
- Thyroid Diseases
Thyroid Diseases
- Certified Medical Interpreters
Certified Medical Interpreters
- Certified Medical Interpreters
Certified Medical Interpreters
- Certified Medical Interpreters
Certified Medical Interpreters
- UAMS Medical Center (Hospital and Clinics) Inclement Weather Policy
UAMS Hospital (Medical Center) Inclement Weather Policy
- Want to Quit Tobacco?
Want to Quit Tobacco?
- Colorectal Cancer Act to Increase Screening Rate for Arkansans
Colorectal Cancer Act to Increase Screening Rate for Arkansans
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
One in 10 couples trying to have a baby will experience some problem with conception. But the good news is there are many treatment options available and a good chance of success.
The majority of couples who follow the complete course of treatment will conceive a child – including couples with unexplained fertility problems, said Aida Shanti, M.D., Director of the Division of Reproductive Endocrinology and Infertility in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS).
Shanti is a board-certified reproductive endocrinologist and the first female physician to direct an infertility and reproductive medicine program in Arkansas. She previously was director of the in-vitro fertilization program at Emory University in Atlanta.
“In most cases we can identify the condition that is preventing pregnancy,” Shanti said. “But if not, chances are still good that there are treatments that will lead to conception.”
The key for couples, Shanti said, is not to wait to visit a reproductive specialist if they think there is a problem. For couples with the woman older than 34, Shanti recommended seeing a specialist if they have not been able to conceive after three to six months. For younger couples, she recommended seeing a specialist after a year of attempting to conceive.
“They shouldn’t get worried, because there are a lot of explanations for infertility and a lot of options to help couples, but they should not drag their feet on seeing a specialist,” Shanti said. “Studies have shown that a woman’s chances of conceiving begin to decrease after age 27 and dramatically so after 39.”
The earlier a fertility problem is diagnosed, the better chance the treatment will work, she said. However, just because a woman is having regular periods does not mean there could not be a problem, Shanti cautioned.
Gynecologists and urologists can help a couple pinpoint problems that could cause difficulty conceiving through a variety of tests. In about 40 percent of such cases, the difficulty can be attributed to some male factor, while in 40 percent of the cases the difficulty is related to a female factor. In most of the remaining 20 percent, both partners have some degree of infertility but even those couples can usually conceive with specialized treatment.
A round of simple physical and laboratory tests will be performed on both partners. A semen analysis will make sure the male partner is producing sperm in adequate numbers and that the sperm are active enough to reach the egg.
For women, there are tests on the uterus and the ovulation process. Through an X-ray of the uterus following the injection of a dye, the doctor can determine if the correct anatomy is present and if there is any blockage that would prevent the sperm from reaching the egg.
With detailed information from the tests, infertility treatments can be customized for each case, ensuring the best chance of conception. At UAMS, Shanti said, treatments will typically start with the simplest and least expensive before moving on to more involved procedures.
Treatment for some conception problems can include artificial insemination, or injecting sperm directly into the woman’s uterus. If other treatments fail, one option may be in-vitro fertilization (IVF), where an egg is removed from the woman and fertilized in a lab using the man’s sperm. The fertilized egg, or embryo, is then placed in the woman’s uterus so that she can carry and deliver the baby just like any other mother.
Even if the man has a low sperm count, enough sperm can usually be found and IVF can be effective since the sperm is injected directly into the egg.
Still another option, if either the woman is not producing good quality eggs or the man’s sperm count is so low no sperm can be obtained, is to use a donor. An anonymous egg or sperm donor can be used. In those cases, the couple can be given certain non-identifying information about the donor.
Sometimes, a friend or relative of the couple is willing to provide an egg for fertilization. Whatever the circumstances, the decision to use a donor egg or sperm should be carefully considered and agreed to by both partners, Shanti said.
One of the newest services available at UAMS is a test that can help couples using IVF ensure that certain diseases or disorders will not be passed on to their child. Preimplantation genetic diagnosis (PGD) can be used to identify genetic defects within the embryo created through IVF.
Through PGD, a cell is removed from the embryo and the DNA sequence can be evaluated for several kinds of genetic or chromosomal problems. Shanti said PGD offers a new tool for giving couples peace of mind about the health of their baby.
The test can benefit any couple at risk for passing on a genetic disease or disorder. PGD can also be helpful for women 35 and over.
There are also several types of medications, both pills and injections, which can address problems with ovulation. Shanti said the use of fertility medications, like the other treatments, depends on the diagnosis of the infertility problem and the treatment that will offer the best chance of success.
Minor surgical procedures are also an option for couples to correct anatomy problems that might prevent conception
Costs vary for fertility evaluation and treatment, based on the extent of services needed. In Arkansas, some insurance companies are required by law to cover in-vitro fertilization up to $15,000 in most cases, unless either partner has had a prior surgical sterilization. Patients should first check with the insurance carrier about coverage.
UAMS has been the pioneer and leader in infertility treatment in Arkansas for many years and is the first comprehensive ART (assisted reproductive technology) center in Arkansas. The UAMS program has achieved many Arkansas firsts in infertility treatment including the first IVF procedure in 1988, the first pregnancy through egg donation, and the first babies conceived through intracytoplasmic sperm injection. The IVF delivery rate of the UAMS program continues to outpace the national average year after year.
|